A century of Alzheimer's disease - PubMed (original) (raw)
Review
. 2006 Nov 3;314(5800):777-81.
doi: 10.1126/science.1132814.
Affiliations
- PMID: 17082447
- DOI: 10.1126/science.1132814
Review
A century of Alzheimer's disease
Michel Goedert et al. Science. 2006.
Abstract
One hundred years ago a small group of psychiatrists described the abnormal protein deposits in the brain that define the most common neurodegenerative diseases. Over the past 25 years, it has become clear that the proteins forming the deposits are central to the disease process. Amyloid-beta and tau make up the plaques and tangles of Alzheimer's disease, where these normally soluble proteins assemble into amyloid-like filaments. Tau inclusions are also found in a number of related disorders. Genetic studies have shown that dysfunction of amyloid-beta or tau is sufficient to cause dementia. The ongoing molecular dissection of the neurodegenerative pathways is expected to lead to a true understanding of disease pathogenesis.
Similar articles
- Piecing together Alzheimer's.
St George-Hyslop PH. St George-Hyslop PH. Sci Am. 2000 Dec;283(6):76-83. doi: 10.1038/scientificamerican1200-76. Sci Am. 2000. PMID: 11103462 Review. No abstract available. - Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.
Narayanan SE, Sekhar N, Rajamma RG, Marathakam A, Al Mamun A, Uddin MS, Mathew B. Narayanan SE, et al. Curr Protein Pept Sci. 2020;21(12):1164-1173. doi: 10.2174/1389203721666200921152246. Curr Protein Pept Sci. 2020. PMID: 32957903 Review. - Shutting down Alzheimer's.
Wolfe MS. Wolfe MS. Sci Am. 2006 May;294(5):72-9. doi: 10.1038/scientificamerican0506-72. Sci Am. 2006. PMID: 16708491 No abstract available. - [Alzheimer's disease: cellular and molecular aspects].
Octave JN, Pierrot N. Octave JN, et al. Bull Acad Natl Med. 2008 Feb;192(2):323-31; discussion 331-2. Bull Acad Natl Med. 2008. PMID: 18819686 Review. French. - Alzheimer's disease: genotypes, phenotypes, and treatments.
Selkoe DJ. Selkoe DJ. Science. 1997 Jan 31;275(5300):630-1. doi: 10.1126/science.275.5300.630. Science. 1997. PMID: 9019820 Review. No abstract available.
Cited by
- Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer's Disease.
Wang L, Shui X, Diao Y, Chen D, Zhou Y, Lee TH. Wang L, et al. Int J Mol Sci. 2023 Nov 13;24(22):16259. doi: 10.3390/ijms242216259. Int J Mol Sci. 2023. PMID: 38003448 Free PMC article. Review. - Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration.
Bravo R, Parra V, Gatica D, Rodriguez AE, Torrealba N, Paredes F, Wang ZV, Zorzano A, Hill JA, Jaimovich E, Quest AF, Lavandero S. Bravo R, et al. Int Rev Cell Mol Biol. 2013;301:215-90. doi: 10.1016/B978-0-12-407704-1.00005-1. Int Rev Cell Mol Biol. 2013. PMID: 23317820 Free PMC article. Review. - Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals.
Lazarczyk MJ, Hof PR, Bouras C, Giannakopoulos P. Lazarczyk MJ, et al. BMC Med. 2012 Oct 25;10:127. doi: 10.1186/1741-7015-10-127. BMC Med. 2012. PMID: 23098093 Free PMC article. Review. - In vitro inhibitory profile of NDGA against AChE and its in silico structural modifications based on ADME profile.
Remya C, Dileep KV, Tintu I, Variyar EJ, Sadasivan C. Remya C, et al. J Mol Model. 2013 Mar;19(3):1179-94. doi: 10.1007/s00894-012-1656-0. Epub 2012 Nov 16. J Mol Model. 2013. PMID: 23229229 - Exploring Methylene Blue and Its Derivatives in Alzheimer's Treatment: A Comprehensive Review of Randomized Control Trials.
Hashmi MU, Ahmed R, Mahmoud S, Ahmed K, Bushra NM, Ahmed A, Elwadie B, Madni A, Saad AB, Abdelrahman N. Hashmi MU, et al. Cureus. 2023 Oct 9;15(10):e46732. doi: 10.7759/cureus.46732. eCollection 2023 Oct. Cureus. 2023. PMID: 38022191 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous